Insmed (INSM) Misses Q1 EPS by 7c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $108.52 +3.91%
Financial Fact:
Interest expense: -769K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Interest expense: -769K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($1.42), $0.07 worse than the analyst estimate of ($1.35). Revenue for the quarter came in at $92.82 million versus the consensus estimate of $90.78 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Wayfair (W) PT Raised to $160 at Truist Securities
- Insulet Corporation (PODD) PT Raised to $163 at TD Cowen
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
